Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|January 11, 2001
Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulceransA M DhopleIndian Journal of Leprosy|February 25, 1998
Comparative in vitro activities of rifamycin analogues against Mycobacterium lepraeA M DhopleArzneimittel-Forschung|April 29, 1999
In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium lepraeA M DhopleInternational Journal of Antimicrobial Agents|September 24, 1999
In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium lepraeA M DhopleMicrobios|October 24, 1998
Factors influencing the in vitro growth of Mycobacterium leprae: effect of inoculumA M DhopleIndian Journal of Leprosy|January 1, 1990
An in vitro culture method for screening new drugs against Mycobacterium lepraeA M Dhople, I OrtegaMicrobios|May 1, 2001
Acid tolerance of Escherichia coli O157:H7 and its survival in apple juiceL Koodie, A M DhopleJournal of Chemotherapy (Florence, Italy)|April 8, 2003
Activities of sitafloxacin (DU-6859a), either singly or in combination with rifampin, against Mycobacterium ulcerans infection in miceA M Dhople, K NambaArzneimittel-Forschung|February 1, 1996
In vitro activity of a new rifamycin derivative against Mycobacterium lepraeA M Dhople, V DimovaPageof 6